Skip to main content
OpenTrials

Clinical trial condition

Non-small Cell Lung Cancer

Explore clinical trials studying Non-small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

1,335 public trials 330 recruiting studies
Refine in advanced search Browse all conditions

Non-small Cell Lung Cancer trial results

Completed

Postoperative Radiotherapy of Non-small Cell Lung Cancer: Accelerated vs. Conventional Fractionation

NCT02189967

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Universitätsklinikum Dresden, Department of Radiation Therapy and Radiation Oncology Dresden, Germany
  • Universitätsklinikum Freiburg, Department of Radiation Therapy and Radiation Oncology Freiburg im Breisgau, Germany
  • Praxis für Strahlentherapie Hamburg-Harburg Hamburg, Germany
  • Universitätsklinikum des Saarlandes, Department of Radiotherapy and Radiation Oncology Homburg, Germany
View Trial Details
Completed

Study of Enzastaurin Versus Placebo With Pemetrexed for Participants With Advanced or Metastatic Lung Cancer

NCT00530621

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fayetteville, Arkansas, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lancaster, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Los Angeles, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tampa, Florida, United States
View all 25 locations
View Trial Details
Completed

An epidemiOlogy Study to deteRmine the Prevalence of EGFR (Epidermal Growth Factor Receptor) muTations in RUSsian Patients With Advanced NSCLC (Non-Small Cell Lung Cancer).

NCT02321046

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Khanti-Manskiysk, Russia
  • Research Site Novisibirsk, Russia
  • Research Site Arkhangelsk, Russia
  • Research Site Barnaul, Russia
View all 26 locations
View Trial Details
Completed

Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors

NCT01803282

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +29 more
Locations
  • Alabama Oncology Birmingham, Alabama, United States
  • Pinnacle Oncology Hematology Scottsdale, Arizona, United States
  • Comprehensive Blood and Cancer Center Bakersfield, California, United States
  • San Diego Pacific Oncology and Hematology Associates, Inc. Encinitas, California, United States
View all 18 locations
View Trial Details
Completed

A Phase 2 Study of CRLX101(NLG207) in Patients With Advanced Non-Small Cell Lung Cancer

NCT01380769

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • State Medical Institution Republican Oncology Center Saransk, Respublika Mordoviya, Russia
  • State Medical Institution Republic Clinical Oncological Center under the Healthcare Ministry of Tatarstan Republic Kazan', Tatarstan Republic, Russia
  • Arkhangelsk Regional Clinical Oncology Center Arkhangelsk, Russia
  • State Healthcare Institution: Bryansk Regional Oncology Center Bryansk, Russia
View all 25 locations
View Trial Details
Completed

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

NCT02223052

Conditions
Acute Myeloid Leukemia, Adenocarcinoma, Adnexal Diseases, +106 more
Locations
  • Scottsdale Healthcare Research Institute Scottsdale, Arizona, United States
  • Mayo Clinic - Arizona Scottsdale, Arizona, United States
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • University of Iowa Iowa City, Iowa, United States
View Trial Details
Completed

A Study of Atezolizumab as First-line Monotherapy for Advanced or Metastatic Non-Small Cell Lung Cancer

NCT02848651

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Veterans Affairs Central California Health Care System Fresno, California, United States
  • Memorial Regional Hospital Hollywood, Florida, United States
  • Florida Hospital Orlando, Florida, United States
  • St. Alexius Medical Center Hoffman Estates, Illinois, United States
View all 20 locations
View Trial Details

Related conditions